Latest News

Merz Aesthetics adds two FDA-approved Belotero HA fillers for midface volume and lip fullness, promising natural movement and long-lasting results.

In a 52-week open-label trial, tildrakizumab-asmn (Ilumya) reduced a mortality-linked DNA methylation clock by up to 0.5 years while clearing psoriasis symptoms.

At the Dermatology Times NP/PA Cutaneous Oncology Workshop in Tampa, Florida, Amit Om, MD, outlined why field-directed therapy is increasingly favored over lesion-directed treatment for actinic keratosis.

At the Cutaneous Oncology Workshop, faculty explored lesion recognition, surgical decision-making, risk stratification, and the evolving role of molecular testing.

Faculty at the Dermatology Times Cutaneous Oncology Workshop addressed real-world questions on mole mapping, biopsy decisions, oral photoprotection, and actinic keratosis treatment.

In the morning session, Experts highlighted evolving photoprotection strategies, field-directed treatment of actinic keratoses, hereditary cancer risk, and practical dermoscopy pearls for APPs.

Are beef tallow balms beneficial for the skin or are they just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Dermatology Times kicks off its first Cutaneous Oncology Workshop, bringing APPs and experts together for practical skin cancer education.

Isotretinoin Effect on Adult Height in Danish Cohort Study

FDA review of BOTOX Cosmetic for masseter prominence signals on-label jawline contouring, trial-backed results, clearer dosing guidance, and safer patient counseling.

Dietary modification may improve disease activity and quality of life in some patients with chronic idiopathic urticaria.

Genetic analysis finds smoking unlikely to cause urticaria, suggesting past links reflect confounding. Find out what this means for triggers and patient care.

Phase 2 SkinJect data support the 200-µg dose and inform Medicus’ FDA-authorized registrational program in Gorlin syndrome.